Aquaculture Vaccines Market Is Moving Towards With Tremendous Growth By 2025

Aquaculture vaccines market share has been witnessing increased traction owing to the growing incidence of fish infections among aquaculture species across the world. Fish farming is one of the prominent businesses across the globe, owing to rising fish consumption that is beneficial for health. But as fish are extremely vulnerable to bacterial and viral infections, they are required to be regularly treated with antibiotics or vaccines.

Recent research has found that growing implementation of antibiotics has been leading toward negative effects on fish health, such as deteriorating resistance power and prevalent reoccurrence of the diseases. Whereas, vaccines tend to provide superior protection against bacterial and viral infections without triggering any negative outcomes on fish health, which will be a major factor augmenting aquaculture vaccines market trends.

Request for a sample copy of this report @

According to an aquaculture vaccines market forecast report, immersion vaccines market will demonstrate considerable growth at 6.7% CAGR over 2019-2025. Uninterrupted exposure of immune cells, which are found in the skin and gills of fish, to antigens will produce a strong and long-term immune response.

Aquaculture vaccines aimed to treat viral diseases held substantial aquaculture vaccine industry share of 15.8% in 2018. According to the National Institute of Health (NIH), the second most predominant disease challenge in fish farming are viral diseases which account for around 23% of incidences across the globe. Increase in number of viral infections like infectious pancreatic necrosis (IPN) and infectious salmon anemia (ISA) will also majorly contribute to improve segment growth and aquaculture vaccines market outlook.

As per aquaculture vaccines industry forecast report, tilapia segment will surpass revenue share of around $45.5 million by 2025. Increasing demand and commercial importance of tilapia in the international market will efficiently drive the segmental growth. According to the Food and Agriculture Organization of the United Nations (FAO), the second most important species of finfish is tilapia which accounted for almost 7.4% of the entire aquaculture production in 2015. Uplifting tilapia production owing to the small production period and simple culture techniques is going to augment tilapia vaccines market share growth in the future.

The UK aquaculture vaccines market held a significant share in 2018 and is projected to accumulate over USD 29.2 million by 2025. The country has been witnessing increasing product consumption promoted by the favorable government initiatives to protect several fish species on verge of extinction. Growing preferences for vaccines over antibiotics will drive UK aquaculture vaccines industry share over 2019-2025.

Request for customization @

Various global aquaculture vaccine market players have been striving to gain a huge chunk of profit in the business by following different growth strategies. Some of the leading industry players operational in global aquaculture vaccines industry include Hipra, Merck & Co., Inc., Zoetis Inc., Virbac, Tecnovax, Nisseiken Co. Ltd. and Veterquimica S.A.

Partial Chapter of the Table of Content

Chapter 4.    Aquaculture Vaccines Market, By Type of Vaccines

4.1. Key segment trends

4.2. Inactivated vaccines

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.3. Live vaccines

4.3.1. Market size, by region, 2014 – 2025  (USD Million)

4.4. Others

4.4.1. Market size, by region, 2014 – 2025  (USD Million)

Chapter 5.    Aquaculture Vaccines Market, By Route of Administration

5.1. Key segment trends

5.2. Immersion vaccines

5.2.1.  Market size, by region, 2014 – 2025 (USD Million)

5.3. Injection vaccines

5.3.1.  Market size, by region, 2014 – 2025 (USD Million)

5.4. Oral vaccines

5.4.1.  Market size, by region, 2014 – 2025 (USD Million)

Chapter 6.    Aquaculture Vaccines Market, By Application

6.1.  Key segment trends

6.2.  Bacterial infection

6.2.1.    Market size, by region, 2014 – 2025 (USD Million)

6.3.  Viral infection

6.3.1.    Market size, by region, 2014 – 2025 (USD Million)

6.4.  Others

6.4.1.    Market size, by region, 2014 – 2025  (USD Million)

Browse full table of contents (TOC) of this report @